Tobias Whelan
Research Subjects
Research Interests
Tobias Whelan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Anaïs Soula
COMPASS Pathways Ltd., London, UK
1 shared publicationAslihan Selimbeyoglu
COMPASS Pathways Ltd., London, UK
1 shared publication- Chenchen Song
Laboratory for Neuronal Circuit Dynamics, Department of Brain Sciences, Imperial College London, London, UK
1 shared publication - Irene Mollinedo-Gajate
Laboratory for Neuronal Circuit Dynamics, Department of Brain Sciences, Imperial College London, London, UK
1 shared publication - Marcos Sintes-Rodriguez
Laboratory for Neuronal Circuit Dynamics, Department of Brain Sciences, Imperial College London, London, UK
1 shared publication Shaun Hurley
COMPASS Pathways Ltd., London, UK
1 shared publication
Latest Publications
- Open Access
Psilocybin rescues sociability deficits in an animal model of autism
Autism spectrum disorder (ASD) is characterized by core deficits in social interaction. The classic serotonergic psychedelic psilocybin has been suggested as a therapeutic agent that may ameliorate in the core symptomology of ASD. We found that the acute response to psilocybin was attenuated in the prenatal valproic acid exposure mouse model of ASD, and importantly, psilocybin rescued the social behavioural abnormalities present in these ASD model mice.
Open AccessPsilocybin rescues sociability deficits in an animal model of autism
Autism spectrum disorder (ASD) is characterized by core deficits in social interaction. The classic serotonergic psychedelic psilocybin has been suggested as a therapeutic agent that may ameliorate in the core symptomology of ASD. We found that the acute response to psilocybin was attenuated in the prenatal valproic acid exposure mouse model of ASD, and importantly, psilocybin rescued the social behavioural abnormalities present in these ASD model mice.